Liposomal camptothecin and 9-nitro-camptothecin: Formulation, pharmacokinetics and preclinical anti-tumor activity

Proceedings of the Controlled Release Society

Volumn , Issue 24, 1997, Pages 919-920

  Chow, D S L ^a   Chen, G ^a   Gong, L ^a   Giovanella, B C ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; LIPOSOME; RUBITECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; RAT; TUMOR; TUMOR VOLUME;

EID: 0030787094     PISSN: 10220178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)